Software addresses specialty's weaknessOne of the nuclear medicine community's major weaknesses in recentyears has been its failure to adequately market the modality'sunique ability to image body metabolism and function. As a resultof this
One of the nuclear medicine community's major weaknesses in recentyears has been its failure to adequately market the modality'sunique ability to image body metabolism and function. As a resultof this deficiency, nuclear medicine has seen procedures slipaway to other imaging modalities, a phenomenon that could havelong-term ramifications for the health of the specialty.
The nuclear medicine community has recognized the gravity ofthe situation, however, and is taking steps to improve its publicimage. One company, MedImage of Ann Arbor, MI, is developing asoftware program called Strategy that guides nuclear medicinephysicians through the development of a marketing plan for theirpractices.
Strategy is designed to help nuclear medicine practices competeon a level playing field for the patient referrals that are becomingincreasingly scarce as payors cut out unnecessary imaging tests,said Sherry Kruse, product manager for MedImage.
"Nobody is out there trumpeting what nuclear medicinedoes," Kruse said. "With the changing health-care environment,there is only going to be so much money to spend on a patient.Referring physicians have to make a decision as to what kind oftest can give them the most information."
Strategy was unveiled in June at the Society of Nuclear Medicinemeeting in Minneapolis. MedImage will sell the software as a CD-ROMin both Windows and Macintosh formats. The product is in betatesting and is expected to be released for sale later this summerat a list price of $4000.
The program has two parts: a tutorial and an information system.The tutorial makes full use of the capabilities of multimedia,using movies and sound to introduce users to the value of marketing.It also takes users through the development of a marketing planby asking questions about their practices.
"There seems to be a hesitance to say you are even doingmarketing, so we try to educate them," Kruse said.
The other half of the product is an information system intowhich users input the names of referring physicians, numbers ofreferrals, types of cases done, and the organizations for whichthe referring physicians work. The program can help nuclear medicinephysicians put together newsletters, questionnaires, surveys,thank-you letters and invitations to seminars that will help buildpractices.
Kruse believes the program will fill a need in the nuclearmedicine community.
"We've heard a lot of doctors talking about developinga strategy or a plan to promote their businesses because theyexpect to see a drop in revenue," she said. "Strategywill help them tailor a plan exactly for their practices."
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.